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Abstract Ty3, a gypsylike retrotransposon of budding yeast, 
integrates at the transcription initiation site of genes transcribed 
by RNA polymerase III (pol III). It was previously shown that 
integration in vitro requires intact promoter elements and the pol 
III transcription factors TFIIIB and TFIIIC. In order to test the 
effect of pol III on integration, increasing amounts of a pol Ill-
containing fraction were added to Ty3 in vitro integration 
reactions. The pol Ill-containing fraction was inhibitory to 
integration. These results are consistent with a model where the 
Ty3 integration complex and pol III recognize similar features of 
the stable transcription complex and compete with each other for 
access to the transcription initiation site. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
A subset of retroelements have been identified which have 
patterns of integration that reflect dramatic insertion bias for 
tRNA genes. These include DRE I [1], a nonLTR retrotrans-
poson from Dictyostelium discoideum, and the Tyl and Ty2 
copialike and Ty3 gypsylike LTR retrotransposons from Sac-
charomyces cerevisiae (reviewed in [2]). DRE I elements are 
close to position —50 nt relative to tRNA gene sequence. Tyl 
and Ty2 genomic elements occur predominately within a re-
gion of about 700 nt upstream of tRNA genes [3-5]. Ty3 is 
even more closely associated with tRNA genes than the other 
elements [6-8]. Of the two staggered nicks introduced by Ty3 
strand transfer into the target, one occurs within 1-2 nt of the 
transcription initiation site and the other 5 nt distal. The 
target region spanned by the staggered cleavage therefore 
overlaps the region contained in the open complex bubble 
formed upon RNA polymerase III (pol III) transcription ini-
tiation [9]. In the case of the Saccharomyces cerevisiae ele-
ments Tyl and Ty3, tRNA gene targeting requires intact pro-
moter elements and other genes transcribed by pol III such as 
5S and U6 genes are also targets [8,10]. Thus, the processes of 
transcription and integration are superficially linked, if not 
actually interdependent. 
The Ty3 element is composed of GAG3 and POL3 genes 
which encode proteins with similar sequence and function to 
those encoded by the retroviral gag and pol genes [11]. Ty3 
proteins condense around the genomic RNA to form a nucle-
oprotein complex referred to as the viruslike particle (VLP), 
which is analogous to the retroviral core particle. After re-
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verse transcription of Ty3 RNA in association with the VLP, 
the DNA copy is integrated into the host genome in a process 
mediated by Ty3 integrase (IN) [12]. Ty3 IN is a homologue 
of retroviral IN. Recombinant retroviral IN has been demon-
strated to have in vitro 3'-end processing and strand-transfer 
activities (reviewed in [13]). Although Ty3 IN has been dem-
onstrated to be required in vivo for 3'-end processing and 
integration of Ty3 DNA, integration activity has only been 
observed in vitro in association with a VLP fraction [14]. 
Despite the many similarities between retroviruses and Ty3 
elements, neither retrovirus integration adjacent to tRNA 
gene targets nor a bias for tRNA gene-containing regions 
has been reported. Although, retrovirus insertion has been 
linked in past studies to genomic DNA which is transcription-
ally active, more recent studies are consistent with widespread 
distribution of integration sites, including regions occupied by 
nucleosomes [15,16]. Features which target retroviral integra-
tion have now been studied in vitro. These studies may also 
provide further insight into the preferences of retroviruslike 
elements. Retrovirus IN strand transfer is enhanced by static 
and induced bends [17-19]. Bent regions within nucleosomes 
and DNA which is bent by specific DNA binding proteins are 
favored integration sites. Not all DNA bending proteins are 
equally active in creating preferred sites, however, as DNA 
bending proteins which occupy the inside of the bend have 
been shown to be effective in targeting integration, while those 
which occupy the outer, distorted side of the bend can ac-
tually inhibit integration [20]. 
In vitro integration of the Ty3 element requires VLPs, and 
the pol III transcription factors TFIIIC and TFIIIB, in addi-
tion to a DNA target [21]. TFIIIC is comprised of six sub-
units and binds to the two internal promoter elements, box A 
and box B, of the tRNA gene (reviewed in [22,23]). This 
factor in turn mediates binding of TFIIIB, the pol III initia-
tion factor. TFIIIB is composed of three subunits, a 70 kDa 
subunit with similarity to the pol II transcription factor 
TFIIB; a 90 kDa subunit, and the TATA binding protein. 
Although TFIIIC is required for binding of TFIIIB, the 
TFIIIB-DNA complex is quite stable and can mediate multi-
ple rounds of pol III transcription in the absence of TFIIIC 
[24]. Whether TFIIIC is associated with the transcribing 
tRNA gene has not been directly tested, although genomic 
footprints of tRNA genes suggest that only TFIIIB may be 
bound [25]. Features which potentially contribute to the tar-
geting of Ty3 to the site of tRNA gene transcription initiation 
therefore include TFIIIC and TFIIIB, as well as topograph-
ical features of the tRNA gene, such as novel chromatin struc-
ture or the bend associated with the transcription initiation 
site [26]. A previous study showed that pol III did not appear 
to be essential in vitro for integration to occur [21]. However, 
it was possible that low levels of pol III present in IIIB and 
IIIC fractions were sufficient for transposition. In such a sce-
nario, open complex formation in that event could participate 
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in display of the target site to the integration complex. An 
alternative possibility is that the features of the stable complex 
could function alternatively to target pol III or the integration 
complex. These models make distinct predictions regarding 
the effect of pol III on integration. The former model would 
predict that transposition is dependent on pol III, while the 
latter would suggest that transposition might be inhibited by 
pol III. The current study was undertaken to determine the 
effect of pol III on in vitro integration. 
2. Materials and methods 
2.1. Strains and culture conditions 
Construction, maintenance, and propagation of plasmids in E. coli 
were performed according to standard methods [27]. Plasmid manip-
ulations in E. coli were carried out using strain HB101 (F~ hsdS20 
[rB- mB-] recA13 !euB6 ara-14 proA2 lacYl galK2 rpsL20 [Sm
r] xyl-5 
mtl-1 supE44). Transformation and culturing of 5*. cerevisiae strains 
were according to standard methods [28]. The S. cerevisiae strains 
used in this study were AGY9 (MATa ura3-52 his4-539 lys2-801 
trpl-A63 !eu2Al sptS) and yTM442 {MATa trpl-H3 ura3-52 his3-
A200 ade2-101 lys2-l !eu2-Al canl-100) (unpublished data, T. Menees 
and S.B. Sandmeyer). Plasmids were transformed into yeast by the 
method of Ito [29]. Synthetic medium used for plasmid selection was 
made according to standard protocols. 
2.2. Plasmid construction 
Plasmids were constructed by standard techniques. The construc-
tion of the plasmid pDLC374 has been described previously [8] (see 
also Fig. 1). It carries the 2u. origin of replication for maintenance in 
yeast, and the HIS3 gene for selection. It also carries a modified SUP2 
tRNATyr gene. The positive control plasmid pTM842 was derived 
from pDLC374 via an in vivo integration of Ty3 at position —1, 
relative to the nt of tRNA gene transcription initiation in an orienta-
tion such that transcription from the tRNA gene and from the Ty3 
promoter were divergent [30]. The plasmid pEGTy3-l has been de-
scribed previously [31]. It carries the yeast 2|x origin of replication and 
the URA3 gene. Ty3 was under the transcriptional control of the 
GAL1-10 UAS to confer galactose inducibility upon Ty3. The plasmid 
pTZl carried the SUP4 tRNA1''"' with a G62C mutation that in-
creased promoter efficiency [32]. 
2.3. Preparation and fractionation of RNA polymerase III extract 
A yeast extract which supported transcription by pol III was gen-
erated according to the method of Klekamp and Weil [33], with mod-
ifications introduced by Kassavetis et al. [32]. Yeast strain yTM442 
was grown to OD60o of 3-5 in YPD (2% yeast extract, 1% peptone, 
2% dextrose). The cells were harvested and washed once with water. 
The cell pellet was resuspended in 2 ml solubilization buffer (200 mM 
Tris-HCl pH 8.1, 10 mM MgCl2, 1 mM EDTA, 10 mM 2-mercaptoe-
thanol [BME], 1 mM phenylmethylsulfonyl fluoride [PMSF], 1 ug/ml 
leupeptin, 1 ug/ml pepstatin A) per gram of cell pellet. Typically, 12 1 
of yeast were used per preparation, giving approximately 100-120 g of 
cell pellet. All subsequent manipulations were done either at 4°C or 
on ice. The slurry was lysed using a Bead-Beater (BioSpec Products) 
and 0.5 mm glass beads. Briefly, the cell slurry was combined with 0.5 
volumes chilled glass beads, and treated in the bead beater for 30 s, 
followed by 2.5 min cooling in an ice/NaCl slurry at — 17°C. This was 
repeated 14 times. An S100 fraction was generated by centrifuging the 
lysate for 1 h at 42000 rpm in a Beckman Ti60 rotor at 4°C. This 
SI00 was subjected to ammonium sulfate precipitation, and the ma-
terial which was soluble between 35 and 70% saturation at 0°C was 
applied to a 2.5 X 20 cm Bio-Rex 70 cation exchange column (BioRad) 
at a flow rate of 1 ml/min. The column was washed with one volume 
buffer D (10% glycerol, 20 mM HEPES pH 7.8, 5 mM MgCl2, 1 mM 
DTT, 1 mM PMSF, 1 ug/ml leupeptin, 1 ug/ml pepstatin A) contain-
ing 250 mM KC1. A fraction containing TFIIIB, TFIIIC, and pol III 
was eluted with buffer D containing 500 mM KC1. The peak protein 
fractions were pooled and dialyzed against buffer C (20% glycerol, 100 
mM NaCl, 20 mM HEPES, pH 7.8, 1 mM EDTA, 1 mM PMSF, 
1 ug/ml leupeptin, 1 ug/ml pepstatin A) and stored at —70°C. This 
was termed the BR500. The protein concentration was measured by 
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the method of Bradford [34]; the concentration of protein in the 
pooled fraction was typically 2-5 mg/ml. 
The BR500 was further fractionated using DEAE-Sephadex. Typi-
cally, 1 mg of protein was loaded per ml of column resin. The BR500 
was adjusted to 10 mM MgCl2, and applied to the column. The 
TFIIIB-, IIIC-, and pol Ill-containing fractions were eluted with buf-
fer E (buffer D with 10 mM MgCl2 instead of 5 mM) containing 100, 
250, and 500 mM NaCl, respectively. The peak protein fractions were 
identified and pooled. The fractions were dialyzed against buffer C as 
above, and stored at —70°C. The protein concentration of pooled 
fractions was determined by the method of Bradford [34]. The 100 
mM NaCl fraction was typically 1-3 mg/ml, the 250 mM NaCl frac-
tion was typically 0.5-1.5 mg/ml, and the 500 mM NaCl fraction was 
typically 0.2-0.5 mg/ml. 
2.4. In vitro pol HI transcription assays 
In vitro transcriptions were performed using the yeast extract gen-
erated as above. The reactions contained 110 mM NaCl, 8 mM 
MgCl2, 20 mM HEPES pH 7.8, 250 uM ATP, CTP, UTP, 15 uM 
[a-32P]GTP (16.7 Ci/mmol), 75 fmol template tRNA gene, and 800 ng 
pIBI20 carrier DNA in a volume of 50 ul. The reactions were typically 
incubated for 30 min at 30°C. Some were incubated for 15 min at 
15°C, as noted in the text. The reactions were terminated by the 
addition of 150 ul of stop buffer (27 mM EDTA, 0.3% SDS, 0.3 
ug/ul salmon sperm DNA, and 1.3 M LiCl) [35]. The products were 
extracted with phenol/chloroform, and precipitated with ethanol in 
the presence of 2 M NH4OAC. After a 70% ethanol wash, the prod-
ucts were dried and resuspended in 5 JJ.1 formamide containing 0.1% 
bromophenol blue, 0.1% xylene cyanol FF. The products were sepa-
rated by electrophoresis on a denaturing 8% polyacrylamide gel (20:1 
acrylamide:bisacrylamide), and visualized by autoradiography. In 
some cases, the gel was dried, exposed to a Molecular Dynamics 
phosphorimager screen, and the amount of radioactivity incorporated 
into the transcription products quantitated using the ImageQuant 
software. Aliquots of 5 ul and 9 ul were used to monitor the activity 
of the BR500 and DEAE fractions, respectively. 
2.5. Viruslike particle preparation 
Ty3 VLPs were isolated from yeast strain AGY9 essentially as 
described [11,36]. Briefly, cells were transformed with pEGTy3-l 
and grown to mid-log phase in liquid synthetic medium lacking uracil 
and containing 2% each raffinose, glycerol, and lactic acid as a carbon 
source. The cultures were diluted 1:30 into medium containing 2% 
galactose to induce Ty3 expression from pEGTy3-l. Cells were grown 
to an OD600 of approximately 1.5 and harvested. The cell pellets were 
resuspended and the cells made into spheroplasts with zymolyase. 
These were lysed with glass beads and the cell debris removed by 
centrifugation. The extract was fractionated by velocity sedimentation 
in a 10%/30%/70% sucrose gradient as described. Fractions containing 
peak amounts of VLPs were pooled, and the VLPs were concentrated 
by centrifugation. The pellets were resuspended in 100 ul buffer B 
(Mg2+) (15 mM KC1, 5 mM MgCl2, 10 mM HEPES pH 7.8, 10% 
glycerol) and stored at —70°C. Protein concentration was measured 
by the method of Bradford [34] and was typically 1-3 mg/ml. In vitro 
integration activity was stable for at least 3 months (CM. Connolly 
and S.B. Sandmeyer, unpublished data). 
2.6. In vitro integration assay 
In vitro integration assays were performed as described previously 
[21] by combining 400 ng target plasmid pDLC374, pol III extract, 
and 2.5 ug Ty3 VLPs on ice. Standard integration reactions contained 
65 mM NaCl, 5 to 10 mM MgCl2, 20 mM HEPES pH 7.8, and 1 mM 
DTT in a 50 ul volume. Assays were incubated for 15 min at 15°C. 
The reaction was terminated by the addition of 150 ul of stop buffer 
(27 mM EDTA, 0.3% SDS, and 0.3 mg/ml proteinase K) followed by 
incubation for 30 min at 37°C. The reactions were extracted with 
phenol/chloroform, and the DNA was precipitated with ethanol in 
the presence of 2 M NH4OAc, and collected by centrifugation at 
lOOOOXg for 30 min at 4°C. The pellets were washed with 70% etha-
nol, dried, and dissolved in 50 ul of buffer containing 10 mM Tris-
HCl, pH 8.0 and 1 mM EDTA. The products were analyzed by 
polymerase chain reaction (PCR) [30]. 
Integration was detected by PCR amplification of a diagnostic frag-
ment using primers which annealed in Ty3 (primer 278) and upstream 
of the modified tRNA gene carried on pDLC374 (primer 279) as 
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described previously [30] and as illustrated in Fig. 1. A 474 bp product 
is generated in a PCR reaction using the primer set 278/279 from 
plasmids containing Ty3 insertions at position —1 in the orientation 
where the direction of Ty3 transcription is divergent from that of the 
tRNA gene. PCRs contained 4 mM MgCl2, 500 uM dNTPs, 200 uM 
primers, 200 ng gelatin (Eastman Organic Chemicals), 27 Ci/mol 
[32P]dATP, and 2.5 U Taq polymerase (Perkin Elmer) in a 75 al 
volume. Reactions were cycled 27-29 times in a DNA Thermal Cycler 
480 (Perkin Elmer). DNA was denatured at 94°C for 60 s, annealed at 
50°C for 30 s, and extended at 65°C for 45 s. In reactions to monitor 
linearity of the assay, increasing amounts of plasmid, pTM842, a 
target plasmid containing a Ty3 insertion, were combined with the 
target pDLC374 for a total of 25 ng, the approximate amount of 
DNA recovered from integration reactions. Products were fractio-
nated by electrophoresis on 8% polyacrylamide gels (37.5:1 acrylami-
de:bisacrylamide) and stained with ethidium bromide. The bands cor-
responding to the PCR products were excised, and Cerenkov 
radiation measured. 
In order to normalize for the amount of target plasmid recovered 
from integration reactions in the 278/279 PCR reactions, PCRs were 
performed using primers which detect the HIS3 gene (primers 284 and 
285) [30]. This gene is carried on the target plasmid. The PCR reac-
tions were as above, except that reactions contained 2.5 mM MgCl2 
and gelatin was omitted, and primers 284 and 285 were used. The 
reactions were cycled sixteen times, with a denaturation/annealing/ex-
tension profile of 94°C for 45 s, 55°C for 30 s and 72°C for 30 s. The 
PCR products were treated as described above. 
3. Results 
In vivo integration of Ty3 upstream of a tRNA gene on a 
plasmid target showed that Ty3 position specific integration 
requires a transcriptionally competent tRNA gene. In vitro 
experiments using pol III, TFIIIB and TFIIIC containing 
fractions showed that TFIIIB and TFIIIC were sufficient for 
integration, but did not further address the role of pol III. In 
order to determine whether pol III could further contribute to 
targeting, a quantitative PCR assay of integration was used to 
measure the effects of increasing the amount of a pol Ill-
containing fraction on Ty3 integration activity. 
As described previously [21], pol III and pol III transcrip-
tion factors were prepared by passage of a crude extract over 
Bio-Rex 70 and subsequent fractionation on DEAE Sepha-
dex. The BR500 fraction was eluted from the Bio-Rex 70 
column at 500 mM NaCl. The TFIIIB-, TFIIIC-, and pol 
Ill-containing fractions eluted at 100, 250, and 500 mM 
NaCl, respectively, from DEAE Sephadex. These fractions 
were assayed using the pTZl SUP4 tRNATyr gene template. 
All three fractions were required for transcription activity, 
indicating that, by this criterion the factors were present in 
discrete fractions. As indicated above, single fractions were 
not sufficient to support integration, but the combination of 
TFIIIC and TFIIIB resulted in integration activity. 
To investigate the possible effect of pol III on integration, 
integrations were assayed using a quantitative PCR assay. The 
inclusion of [32P]dATP in the assay allowed accurate measure-
ment of the amount of product formed. PCR conditions were 
determined under which product formation increased linearly 
with the amount of template. When input integration template 
pTM842 ranged from 2.5 to 50 amol, the 278/279 PCR prod-
ucts increased linearly, and when target HIS3-marked 
pDLC374 input template ranged from 4.5 to 18 fmol the 
284/285 PCR products increased linearly (unpublished data, 
C M . Connolly and S.B. Sandmeyer). The amount of product 
from the 278/279 PCR of experimental samples was normal-
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Fig. 1. PCR assay for Ty3 position specific integration [30]. VLPs 
shown in upper left function as the source of Ty3 DNA and inte-
grase activity. Integration of Ty3 DNA into the target plasmid 
pDLC374 is monitored by PCR using one primer which anneals 
within Ty3 (primer 278) and one primer which anneals to the target 
plasmid (primer 279). A 474 bp diagnostic fragment is generated 
from products of the integration reaction which contain insertions. 
This assay detects insertions only in one orientation, but in vivo, in-
sertions occur in both orientations into target plasmids. As a con-
trol, levels of a PCR product generated using primers which anneal 
within the HIS3 gene on pDLC374 (primers 284 and 285) are also 
monitored and recovery of Ty3 insertion product is normalized to 
the amount of HIS3 product. 
ized to the amount of product from the corresponding 284/ 
285 PCR for the same reaction. 
The effect of addition of the pol Ill-containing fraction to 
in vitro integration reactions was examined. Integrations were 
performed with a constant amount of TFIIIB- and TFIIIC-
containing fractions (Fig. 2) and variable amounts of pol III. 
Increasing the amount of the pol Ill-containing fraction re-
sulted in decreasing levels of Ty3 integration. The inclusion of 
15 (il of the pol Ill-containing fraction resulted in approxi-
mately 80% less integration than in the reaction with no pol 
III added. Although the absolute amount of the active factors 
in each fraction was not determined, TFIIIB is limiting for 
transcription under these conditions. However, it was possible 
that another component of the pol Ill-containing fraction was 
responsible for the decrease in integration activity. For exam-
ple, nuclease activity might preferentially degrade the integra-
tion products. 
In order to determine if contaminating nucleases were re-
sponsible for the inhibitory effect of the pol III fraction on 
integration, aliquots of that fraction were incubated with 
completed integration reactions (performed in the absence of 
the pol III fraction) (Fig. 3). In vitro integrations were per-
formed using BR500, and the products were processed and 
collected. Aliquots of products of the integration reactions 
were incubated with increasing amounts of the pol Ill-con-
taining fraction in reactions identical to integration reactions, 
except that no VLPs or transcription factor fractions were 
added. The samples were processed as for integrations, and 
the level of integration products was examined by quantitative 
PCR assay. The addition of the pol Ill-containing fraction did 
not decrease the amount of integration products, indicating 
that there was no nuclease activity which preferentially af-
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fected the amount of integration product in presence of the 
pol Ill-containing fraction. 
Polyclonal antibodies were used to determine whether pol 
III was the component of the fraction responsible for the 
inhibition of integration. Antibodies raised against either pol 
III or one of two pol III subunits, C34 or C53 [37], were 
examined for their effect on both in vitro tRNA gene tran-
scription and the inhibitory activity found in the pol Ill-con-
taining fraction. Previous work had shown that these anti-
bodies were inhibitory to pol III transcription. The pol Ill-
containing fraction was preincubated with increasing amounts 
of either pre-immune or post-immune IgG fraction, and the 
effects on both transcription and integration were examined. 
As was previously observed, all three post-immune IgG frac-
tions were found to inhibit pol III transcription, while the pre-
immune IgG fraction did not inhibit transcription to an ap-
preciable degree (Fig. 4). This was consistent with results re-
ported previously [37]. Addition of the anti-pol III IgG frac-
tion, together with the pol III fraction, blocked the 
integration-inhibitory activity seen in the pol Ill-containing 
fraction (Fig. 5A, top). Antibodies raised against the C34 
subunit showed a moderate blocking of the integration-inhib-
itory activity (Fig. 5A, middle) but did not completely reverse 
the effect of pol III, while antibodies raised against the C53 
subunit did not block inhibition of integration (Fig. 5A, bot-
tom). The pre-immune IgG fraction did not block integration 
inhibition by the pol Ill-containing fraction (Fig. 5B). These 
results argued that it is pol III which caused inhibition of Ty3 
integration. 
200 
o 100 
ul pol III fraction 
Fig. 3. Examination of nuclease activity in the pol Ill-containing 
fraction. In vitro integration reactions were performed using BR500 
and processed as described in Section 2. The integration products 
from ten separate reactions were combined. Aliquots were incubated 
with increasing amounts of the pol Ill-containing fraction, as noted, 
for 15 min at 15°C. The reaction conditions were the same as for 
the titration of the pol Ill-containing fraction (Fig. 2), except that 
VLPs and other fractions were absent. The reactions were termi-
nated as for integrations, and analyzed using quantitative PCR. In-
tegration levels detected in PCRs performed with the primer set 
278/279 were normalized to amounts of target plasmid detected in 
PCRs using the primer set 284/285. The data shown are the average 
of two experiments. Product levels are presented as a percentage of 
product levels in reactions to which no pol III was added. 
1201 
3 6 
\\\ pOl 
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Fig. 2. Titration of the pol Ill-containing fraction. In vitro integra-
tion reaction components, except for VLPs, were assembled on ice. 
Transcription complexes were allowed to form by incubating for 15 
min at 15°C. VLPs were added and the reactions were incubated 
for 15 min at 15°C. The reactions were terminated and processed as 
described in Section 2. Increasing amounts of the pol Ill-containing 
fraction were added to integration reactions containing 15 ul of 
TFIIIB and 5 ul of TFIIIC. These reactions were performed in trip-
licate (except for the 9 ul sample which was performed in duplicate) 
and the points represent the average of those results. The error bars 
show the standard deviation. Integration levels are presented as a 
percentage of integration levels in reactions to which no pol III was 
added. The reactions were terminated and analyzed using quantita-
tive PCR. Integration levels detected in PCRs performed with the 
primer set 278/279 were normalized to amounts of target plasmid 
detected in PCRs using the primer set 284/285. 
4. Discussion 
The concentration of a pol Ill-containing fraction in the 
Ty3 in vitro integration reaction correlated inversely with 
the amount of integration of Ty3 into the tRNA gene target. 
These results, derived using a quantitative in vitro integration 
assay and anti-pol III IgG to identify the inhibitory compo-
nent of the polIII fraction, supported the findings of the pre-
vious study that pol III is not required for targeting. More-
over, the findings in this study suggest that the polymerase 
and integration complex access the target by mutually exclu-
sive contacts. 
Despite the proximity of the Ty3 integration and pol III 
transcription initiation sites, open complex formation appears 
not to be required for Ty3 targeting. This result extends the 
conclusions of previous in vivo experiments which argued that 
transcription is not required for Ty3 integration. In one case, 
the nontemplate strand purines including and surrounding the 
transcription initiation site were substituted with pyrimidines 
[8]. As a result of these changes, the major site of transcription 
initiation moved downstream by several nucleotides, to the 
nearest available purine, and the level of tRNA expression 
in vivo and in vitro was reduced. Several Ty3 integrations 
into this target were characterized. However, the most fre-
quently used integration site was actually one nucleotide up-
stream of the most frequently used position of integration in 
the wt gene. Therefore, in this context, as opposed to the 
native context, the most common integration site did not co-
incide with the most common transcription initiation site. If 
the nucleotide of transcription initiation were mechanistically 
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Fig. 4. Transcription inhibition by polyclonal antibodies. The effects 
on in vitro transcription of antibodies raised against either pol III 
and one of two subunits of pol III (C34 or C53) were examined. In-
creasing amounts of antibodies, as noted in the graphs, were prein-
cubated with 15 ul pol Ill-containing fraction for 1 h at 4°C. These 
were then used in transcription reactions with 10 ul TFIIIC-contain-
ing fraction and 7.5 ul TFIIIB-containing fraction. The plasmid 
pTZl, carrying a SUP4 tRNATyr was used as a template. The reac-
tions were assembled on ice, then incubated for 15 min at 15°C, 
and processed as described in Section 2. The products were sepa-
rated by electrophoresis on 8% polyacrylamide gels (20:1 acrylami-
de:bisacrylamide). The gels were dried, exposed to a phosphorimag-
er screen and the intensity of the bands determined using 
ImageQuant software. The transcriptions were performed twice, and 
representative data is shown. The data shown are presented as rela-
tive to reactions in which no antibody was present in the preincuba-
tion and are from one representative experiment. A: Effect of post-
immune IgG fraction on in vitro transcription. Top, anti-pol III 
IgG; middle, anti-C34 IgG; bottom, anti-C53 IgG. B: Effect of pre-
immune IgG fraction on in vitro transcription. Top, anti-pol III 
pre-immune IgG; middle, anti-C34 pre-immune IgG; bottom, anti-
C53 pre-immune. 
linked to integration, these sites would be predicted to show 
such linkage. 
The second result that suggested that transcription is not 
required for integration is that tRNA genes which appear to 
be transcriptionally less active can be as competent as wt 
genes as targets for Ty3 integration [8]. For example, the 
sup2 tRNA gene modified by substitution of pyrimidines for 
purines in the vicinity of the initiation site showed levels of 
transcripts in vivo and in vitro which were about one-twenti-
eth those of the wt gene. When the modified gene was inserted 
in tandem with a wt SUP2 tRNA gene target, however, a 
similar number of insertions was recovered into each gene. 
Similarly, the level of transcripts produced from a mutant 
SUP2 tRNA gene in which the box A region was deleted 
and a synthetic box A sequence was inserted upstream of 
the natural position was reduced compared to wt SUP2, but 
this gene was used at a frequency similar to that of the wt 
gene when carried on the same target plasmid. Although these 
two examples did not prove that transcription is not required 
for targeting, they did suggest that transcription is not limit-
ing for the integration reaction. 
Antibodies raised against pol III blocked integration inter-
ference by the pol III fraction. The addition of the pol Ill-
containing fraction reduced integration up to 80%. However, 
preincubation of the pol Ill-containing fraction with polyclo-
nal antibodies raised against pol III blocked the ability of the 
fraction to inhibit integration. This was consistent with the 
interpretation that the component of the pol III transcription 
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Fig. 5. Effect of polyclonal antibodies on Ty3 integration inhibition 
by the pol Ill-containing fraction. Polyclonal antibodies raised 
against pol III or one of two pol III subunits (C34 or C53) were ex-
amined for their effect on the Ty3 integration-inhibitory activity 
seen in the pol Ill-containing fraction. Increasing amounts of anti-
bodies were preincubated with 15 u.1 pol Ill-containing fraction for 
1 h at 4°C. In vitro integration reactions were performed with these 
together with 10 ul TFIIIC-containing fraction and 7.5 ul TFIIIB-
containing fraction as described in Section 2. The reaction were as-
sembled and incubated for 10 min on ice, then incubated for 15 
min at 15°C and processed as described in Section 2. The data 
shown are normalized to reactions in which no antibody was 
present in the preincubation. The experiments were performed twice, 
and representative data is shown. The integration levels were as-
sayed using quantitative PCR. Integration levels detected in PCRs 
performed with the primer set 278/279 were normalized to amounts 
of target plasmid detected in PCRs using the primer set 284/285. A: 
Effect of post-immune IgG fraction on the integration-inhibitory ac-
tivity present in the pol Ill-containing fraction. Top, anti-pol III 
IgG; middle, anti-C34 IgG; bottom, anti-C53 IgG. B: Effect of pre-
immune IgG fraction on the integration-inhibitory activity present 
in the pol Ill-containing fraction. Top, anti-pol III pre-immune 
IgG; middle, anti-C34 pre-immune IgG; bottom, anti-C53 pre-im-
mune. 
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extract which interfered with integration was, in fact, pol III. 
Blocking of the interference attributed to pol III was also 
observed for anti-C34 IgG, although to a lesser extent. It 
was not observed, however, for the anti-C53 IgG. Cross-link-
ing experiments have mapped the positions of the C34 subunit 
and the C53 subunit proximal and distal to the transcription 
initiation site, respectively [38]. Thus, one explanation for the 
difference in effectiveness of blocking between these two anti-
sera is that antibody against the C53 subunit is directed distal 
to the region accessed by the integration complex, potentially 
presenting less of an obstacle to pol III binding at the target 
site. The C53 subunit is reported to be more loosely associated 
with the pol III complex [39] so it is also possible that it is 
dislodged from the polymerase by its interaction with the anti-
body, leaving the remainder of the polymerase available to 
bind to the target. 
Data in the current study are consistent with mutual exclu-
sion or interference of the integration complex and pol III at 
the target site. However, whether the integration complex and 
pol III recognize the same features or different target features 
was not addressed by these experiments. No striking similarity 
in primary sequence has been observed between known Ty3 
components of the integration complex and potential compo-
nents of the stable transcription complex or subunits of pol III 
present in the yeast genome data base (unpublished data, 
C M . Connolly and S.B. Sandmeyer). Nevertheless, it is pos-
sible that some element of the integration complex has struc-
tural similarity to transcriptional components. For example, 
previous experiments have provided support for the existence 
of a heterodimeric Ty3 reverse transcriptase composed of one 
reverse transcriptase and one reverse transcriptase-IN fusion 
protein [11,14] as is the case for RSV (reviewed in [40]). RNA-
and DNA-dependent polymerases have some global similar-
ities in their so-called right hand three-dimensional structure. 
One attractive, but highly speculative, explanation for the 
observed interference is that the integration complex actually 
resembles one or more subunits of the stable transcription 
complex or polymerase III and docks at the target through 
interactions mediated by that component. 
The targeting of several retrotransposons with tRNA genes 
in different organisms encourages the search for global regu-
latory significance of the association. In the case of Ty3, in-
tegration of the element adjacent to at least one tRNA gene 
was found not to significantly disrupt expression of the tRNA 
gene [41]. Nevertheless, disruption of tRNA gene promoters 
did relieve an apparent repression of Ty3 gene expression 
suggesting that tRNA genes could potentially limit the activity 
of retrotransposons. Whether the competition observed here 
might have any similar physiological outcome was not ad-
dressed in this study. In one study a tRNA gene could be 
footprinted in vivo, suggesting a high percentage of occu-
pancy of the gene by transcription factors [25]. However, 
the percentage of genes actually occupied by pol III was not 
estimated. Ty3 is naturally transpositionally active only in 
cells which have recently mated [42]. If pol III occupancy of 
tRNA genes or particular sets of tRNA genes were low during 
this time, the results of this study suggest that it could en-
hance their use as targets relative to other times in the yeast 
life cycle. The effect of VLPs on transcription was not meas-
ured quantitatively in this study. However, physiological Ty3 
transposition does not occur at high frequencies. Therefore, 
transient blocking of pol III access to tRNA genes by Ty3 
integration complexes is unlikely to have major regulatory 
implications even if it occurs transiently. 
The results of this study argue, that although a tRNA gene 
must be transcriptionally competent, pol III does not contrib-
ute directly to Ty3 target establishment. In contrast, the fea-
tures of the transcription complex which target pol III tran-
scription may resemble those which target integration. 
Therefore, transcription and integration are mutually exclu-
sive activities. 
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